Molecular analysis of serum and bronchoalveolar lavage in a mouse model of influenza reveals markers of disease severity that can be clinically useful in humans

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Kumar, Yadunanda ^a,b   Liang, Cui ^a   Limmon, Gino V ^a   Liang, Li ^a   Engelward, Bevin P ^a,b   Ooi, Eng Eong ^a,c   Chen, Jianzhu ^a,d   Tannenbaum, Steven R ^a,b  

^a SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; MOLECULAR MARKER; PROTEOME;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EXPERIMENTAL MODEL; HUMAN; INFLUENZA A; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LONGITUDINAL STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG LAVAGE; MACROPHAGE ACTIVATION; MOLECULAR MODEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN TRANSPORT; VIREMIA; VIRUS STRAIN;

ACUTE LUNG INJURY; ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; ORTHOMYXOVIRIDAE INFECTIONS; PROTEOME; SEVERITY OF ILLNESS INDEX;

EID: 84895526070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086912     Document Type: Article

References (31)

1. Clark NM, Lynch JP 3rd (2011) Influenza: epidemiology, clinical features, therapy, and prevention. Semin Respir Crit Care Med 32: 373-392.
2. Belongia EA, Irving SA, Waring SC, Coleman LA, Meece JK, et al. (2011) Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 304: 1091-1098.
3. Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF (2012) Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol 2: 276-286.
4. Zheng D, Limmon GV, Yin L, Leung NH, Yu H, et al. (2012) Regeneration of alveolar type I and II cells from Scgb1a1-expressing cells following severe pulmonary damage induced by bleomycin and influenza. PLoS One 7: e48451.
5. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206: 79-87.
6. Brandes M, Klauschen F, Kuchen S, Germain RN (2013) A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154: 197-212.
7. Lee N, Wong CK, Chan PK, Chan MC, Wong RY, et al. (2011) Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 6: e26050.
8. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, et al. (2008) Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167: 775-785. (Pubitemid 351451744)
9. Paquette SG, Banner D, Zhao Z, Fang Y, Huang SS, et al. (2012) Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One 7: e38214.
10. Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, et al. (2006) Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann Acad Med Singapore 35: 783-789. (Pubitemid 46045347)
11. Fouchier RA, Bestebroer TM, Herfst S, Van Der Kemp L, Rimmelzwaan GF, et al. (2000) Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol 38: 4096-4101. (Pubitemid 32233210)
12. Wang R, Sheng ZM, Taubenberger JK (2009) Detection of novel (swine origin) H1N1 influenza A virus by quantitative real-time reverse transcription-PCR. J Clin Microbiol 47: 2675-2677.
13. Kumar Y, Liang C, Bo Z, Rajapakse JC, Ooi EE, et al. (2012) Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. PLoS Negl Trop Dis 6: e1887.
14. Wattiez R, Falmagne P (2005) Proteomics of bronchoalveolar lavage fluid. J Chromatogr B Analyt Technol Biomed Life Sci 815: 169-178. (Pubitemid 40126399)
15. Dedon PC, Tannenbaum SR (2004) Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423: 12-22. (Pubitemid 38202218)
16. Yin L, Xu S, Cheng J, Zheng D, Limmon GV, et al. (2013) Spatiotemporal quantification of cell dynamics in the lung following influenza virus infection. J Biomed Opt 18: 46001.
17. Yamada Y, Limmon GV, Zheng D, Li N, Li L, et al. (2012) Major shifts in the spatio-temporal distribution of lung antioxidant enzymes during influenza pneumonia. PLoS One 7: e31494.
18. Steinberg BE, Goldenberg NM, Lee WL (2012) Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods. Antiviral Res 93: 2-15.
19. Wang S, Le TQ, Kurihara N, Chida J, Cisse Y, et al. (2010) Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J Infect Dis 202: 991-1001.
20. Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, et al. (1995) Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 268: R78-84.
21. Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, et al. (2013) Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation. Cell 154: 213-227.
22. Martinez-Ocana J, Olivo-Diaz A, Salazar-Dominguez T, Reyes-Gordillo J, Tapia-Aquino C, et al. (2013) Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09. J Clin Virol 58: 108-113.
23. Matsumoto Y, Kawamura Y, Nakai H, Sugata K, Yoshikawa A, et al. (2012) Cytokine and chemokine responses in pediatric patients with severe pneumonia associated with pandemic A/H1N1/2009 influenza virus. Microbiol Immunol 56: 651-655.
24. Bradley-Stewart A, Jolly L, Adamson W, Gunson R, Frew-Gillespie C, et al. (2013) Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09. J Clin Virol 58: 100-107.
25. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, et al. (2002) Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 109: 1311-1319. (Pubitemid 34546895)
26. Magi B, Bargagli E, Bini L, Rottoli P (2006) Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 6: 6354-6369. (Pubitemid 44935519)
27. Lucas R, Verin AD, Black SM, Catravas JD (2009) Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol 77: 1763-1772.
28. Ohlmeier S, Vuolanto M, Toljamo T, Vuopala K, Salmenkivi K, et al. (2008) Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 7: 5125-5132.
29. Greene KE, King TE Jr., Kuroki Y, Bucher-Bartelson B, Hunninghake GW, et al. (2002) Serum surfactant proteins-A and 2D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 19: 439-446. (Pubitemid 34256957)
30. Leth-Larsen R, Nordenbaek C, Tornoe I, Moeller V, Schlosser A, et al. (2003) Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia small star, filled. Clin Immunol 108: 29-37. (Pubitemid 36809213)
31. Akella A, Deshpande SB (2013) Pulmonary surfactants and their role in pathophysiology of lung disorders. Indian J Exp Biol 51: 5-22.